查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1799074

全球疫苗物流市場

Vaccine Logistics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 269 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計2030年全球疫苗物流市場規模將達38億美元

全球疫苗物流市場規模預計在2024年為30億美元，預計到2030年將達到38億美元，2024年至2030年的複合年成長率為4.0%。運輸服務是本報告分析的細分市場之一，預計其複合年成長率為3.8%，到分析期結束時規模將達到22億美元。倉儲服務細分市場在分析期間的複合年成長率預計為4.5%。

美國市場預計將達到 8.267 億美元，而中國市場預計將以 7.3% 的複合年成長率成長

美國疫苗物流市場規模預計2024年達到8.267億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到7.789億美元，在2024-2030年的分析期間內，複合年成長率為7.3%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為1.6%和3.2%。在歐洲，預計德國市場的複合年成長率為2.3%。

全球疫苗物流市場－主要趨勢與促進因素摘要

與其他低溫運輸市場相比，疫苗物流為何顯得特別複雜？

疫苗物流在低溫運輸物流產業中佔據獨特的地位，需要超可靠的溫度控制、時效性強的配送以及跨區域的監管可追溯性。與典型的藥品和易生鮮產品不同，疫苗屬於生技藥品，其溫度閾值要求較低（通常為 2°C 至 8°C），在某些情況下（例如 mRNA 疫苗），甚至需要在 -70°C 的溫度下冷凍運輸。從最初一英里的生產、中間一英里的空運/海運，到最後一英里送達診所和疫苗接種中心，都必須持續保持這些條件。即使是輕微的溫度異常也可能導致疫苗無法使用，造成健康風險、法規不合規和經濟損失。

新冠疫苗的推廣暴露了疫苗物流的規模和複雜性，刺激了對超低溫冷凍庫、物聯網熱包裝和視覺化軟體的投資。不僅是疫情，各國政府、聯合國兒童基金會和全球疫苗免疫聯盟管理的常規免疫計畫每年也需要向偏遠和服務欠缺地區運送數十億劑疫苗。這需要專門的熱包裝（相變材料、真空隔熱板）、被動冷卻箱和多模態協調。其他挑戰包括管理未使用或過期疫苗的逆向物流、簡化通關流程以及與世界衛生組織協調國家免疫計畫。

哪些技術將改變疫苗運輸和儲存的未來？

數位供應鏈平台、即時狀態監控和人工智慧路線規劃正在改變疫苗物流。疫苗包裝和運輸容器中嵌入的互聯感測器技術可即時監測溫度、濕度、振動和光照。這些感測器透過藍牙或行動電話網路將資料傳輸到雲端基礎儀表板，從而實現主動風險規避。醫藥物流供應商現在正在使用人工智慧演算法來預測瓶頸、最佳化配送時間，並根據天氣或地緣政治動盪情況調整貨運。

另一項創新是利用無人機物流和電動車（EV）在偏遠地區和擁塞都市區進行最後一哩配送。太陽能冷藏箱和可攜式疫苗冰箱也在非通電地區部署。數據分析正在改善預測和庫存計劃，減少缺貨和疫苗浪費。區塊鏈實驗正在探索，以實現對疫苗來源、批次記錄和監管審核線索的防篡改追蹤。這些數位層面對於建立信任至關重要，尤其是在監管往往缺乏協調的國際疫苗交易中。

哪裡對專業化疫苗物流的需求成長最快？

受免疫接種計畫擴大、成人疫苗接種率上升以及疫情防治工作的推動，已開發市場和新興市場對專業疫苗物流的需求都在激增。高所得國家正致力於建造季節性流感、呼吸道合胞病毒、帶狀皰疹和新冠肺炎加強劑的彈性低溫運輸。這些地區也正在投資智慧倉庫、溫控配送中心以及疫苗製造商、經銷商和公共衛生系統之間的API整合。

中低收入國家 (LMIC) 高度重視「最後一哩路」覆蓋、低溫運輸電氣化以及加強公私物流夥伴關係。諸如全球疫苗接種計劃 (COVAX)、全球疫苗和免疫聯盟 (Gavi) 的冷鏈設備最佳化平台 (CCEOP) 以及帕斯健康科技 (PATH) 的下一代低溫運輸解決方案等全球衛生舉措正在推動太陽能冰箱、數位疫苗管瓶監測器 (VVM) 和醫護人員培訓的普及。撒哈拉以南非洲、東南亞和拉丁美洲的國家也正在採用國家疫苗物流管理系統 (vLMIS) 來追蹤疫苗劑量、管理庫存和規劃補貨。此外，印度、中國和巴西正在擴大國內疫苗生產，這推動了對國內低溫運輸產能和合規系統的需求。

推動全球疫苗物流市場向前發展的力量有哪些？

疫苗物流市場的成長受到多種因素的推動，包括全球疫苗接種計畫的擴大、對溫度敏感型生技藥品需求的增加，以及公共和私營部門對低溫運輸基礎設施投資的增加。新冠疫情帶來了模式轉移，暴露了全球疫苗分發的脆弱性，並促使人們努力建立更具彈性、更靈活、更可追溯的物流系統。各國政府目前正將低溫運輸物流計畫納入其疫情防範策略和公共衛生預算，以確保長期需求穩定。

醫藥創新也是一大驅動力。隨著mRNA平台、基於載體的疫苗和新型佐劑製劑的發展，疫苗的溫度和處理要求日益複雜。這推動了陸運、空運和海運運輸方式對先進包裝、被動冷卻系統和主動冷藏技術的需求。此外，從世界衛生組織預先認證到國家良好分銷規範 (GDP)，越來越多的國際法規正在推動物流供應商加強其品質保證、文件和風險管理實踐。

私募股權和創投對醫藥物流新興企業的投資，以及全球物流巨頭（例如 DHL、UPS、Kuehne+Nagel）擴大其低溫運輸運力，進一步反映出市場興趣的日益成長。隨著氣候變遷、全球健康威脅以及對公平疫苗取得的需求重塑全球衛生格局，市場格局仍將對從城市中心到鄉村地區以及介於兩者之間的所有地區實現大規模疫苗接種成果至關重要。

部分

服務（運輸、倉儲、加值）、最終用戶（醫院、藥廠/經銷商、其他最終用戶）

受訪公司範例

  • 3PL-Agility
  • AIT Worldwide Logistics
  • AIT Worldwide Logistics
  • AllCargo Logistics
  • American Airlines Cargo
  • Americold Logistics
  • Biocair
  • CEVA Logistics
  • Cold Chain Technologies
  • DB Schenker
  • DHL Global Forwarding
  • DP World
  • DPD/Deutsche Post AG
  • Dulas Ltd.
  • FedEx Corporation
  • Gebruder Weiss
  • IndoSurgicals Pvt. Ltd.
  • Kuehne+Nagel
  • LifeConEx（DHL subsidiary）
  • Nippon Express

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 沒有遵循典型的 LLM 或特定於行業的 SLM查詢，而是建立了一個從世界各地的專家收集的內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP39474

Global Vaccine Logistics Market to Reach US$3.8 Billion by 2030

The global market for Vaccine Logistics estimated at US$3.0 Billion in the year 2024, is expected to reach US$3.8 Billion by 2030, growing at a CAGR of 4.0% over the analysis period 2024-2030. Transportation Service, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$2.2 Billion by the end of the analysis period. Growth in the Warehousing Service segment is estimated at 4.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$826.7 Million While China is Forecast to Grow at 7.3% CAGR

The Vaccine Logistics market in the U.S. is estimated at US$826.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$778.9 Million by the year 2030 trailing a CAGR of 7.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 3.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.

Global Vaccine Logistics Market - Key Trends & Drivers Summarized

What Makes Vaccine Logistics Uniquely Complex Compared to Other Cold Chain Markets?

Vaccine logistics occupies a distinct niche within the cold chain logistics industry, demanding ultra-reliable temperature control, time-sensitive distribution, and regulatory-compliant traceability across geographies. Unlike general pharmaceuticals or perishables, vaccines are biologics with narrow thermal thresholds-often between 2°C and 8°C-and in some cases (like mRNA vaccines) requiring deep-frozen transport at -70°C. These conditions must be maintained continuously through first-mile manufacturing, mid-mile air/sea transport, and last-mile delivery to clinics or immunization centers. Even minor temperature excursions can render vaccines unusable, resulting in health risks, regulatory non-compliance, and financial losses.

COVID-19 vaccine deployment revealed the scale and complexity of vaccine logistics, driving investments in ultra-low temperature freezers, IoT-enabled thermal packaging, and visibility software. Beyond pandemics, routine immunization programs managed by governments, UNICEF, and Gavi require annual delivery of billions of doses to remote and underserved locations. This necessitates specialized packaging (phase-change materials, vacuum insulation panels), passive cooling boxes, and multi-modal coordination. Challenges also include managing reverse logistics for unused or expired doses, ensuring customs clearance efficiency, and coordinating between national immunization programs and global health agencies.

Which Technologies Are Reshaping the Future of Vaccine Transport and Storage?

Vaccine logistics is being transformed by digital supply chain platforms, real-time condition monitoring, and AI-assisted route planning. Connected sensor technologies embedded in vaccine packaging or transport containers monitor temperature, humidity, vibration, and light exposure in real time. These sensors transmit data via Bluetooth or cellular networks to cloud-based dashboards, enabling proactive risk mitigation. Pharmaceutical logistics providers now use AI algorithms to predict bottlenecks, optimize delivery windows, and reroute shipments based on weather or geopolitical disruptions.

Another innovation is the use of drone logistics and electric vehicles (EVs) for last-mile delivery in remote or urban-congested areas. Solar-powered cold boxes and portable vaccine refrigerators are also being deployed in off-grid regions. Data analytics is improving forecasting and inventory planning, reducing both stockouts and vaccine wastage. Blockchain pilots are being explored for tamper-proof tracking of vaccine provenance, batch records, and regulatory audit trails. These digital layers are essential to building trust, especially in international vaccine trade, where regulatory harmonization is often lacking.

Where Is the Demand for Specialized Vaccine Logistics Growing Most Rapidly?

Demand for specialized vaccine logistics is surging across both developed and emerging markets, driven by expanded immunization schedules, adult vaccine uptake, and epidemic preparedness initiatives. In high-income countries, the focus is on building resilient cold chains for seasonal influenza, RSV, shingles, and COVID-19 boosters. These regions are also investing in smart warehousing, temperature-controlled distribution hubs, and API integrations between vaccine manufacturers, distributors, and public health systems.

In low- and middle-income countries (LMICs), the emphasis is on last-mile access, cold chain electrification, and strengthening of public-private logistics partnerships. Global health initiatives-such as COVAX, Gavi’s Cold Chain Equipment Optimization Platform (CCEOP), and PATH’s NextGen cold chain solutions-are driving deployment of solar refrigerators, digital VVMs (vaccine vial monitors), and training for health workers. Countries in Sub-Saharan Africa, Southeast Asia, and Latin America are also adopting national vaccine logistics management systems (vLMIS) to track doses, manage inventories, and plan replenishments. Additionally, domestic vaccine manufacturing growth in India, China, and Brazil is increasing the need for intra-national cold chain capacity and compliance systems.

What Forces Are Powering the Global Vaccine Logistics Market Forward?

The growth in the vaccine logistics market is driven by several factors, including expanded global immunization programs, rising demand for temperature-sensitive biologics, and increasing public and private investment in cold chain infrastructure. COVID-19 created a paradigm shift, exposing vulnerabilities in global vaccine distribution and catalyzing efforts to build more resilient, agile, and traceable logistics systems. National governments are now incorporating cold chain logistics planning into pandemic preparedness strategies and public health budgets, ensuring long-term demand stability.

Pharmaceutical innovation is another driver. With the growth of mRNA platforms, vector-based vaccines, and novel adjuvanted formulations, the temperature and handling requirements of vaccines are becoming more complex. This is stimulating demand for advanced packaging, passive cooling systems, and active reefer technologies across land, air, and sea modes. Moreover, international regulatory tightening-from WHO prequalification to national Good Distribution Practices (GDP)-is pushing logistics providers to enhance quality assurance, documentation, and risk management practices.

Private equity and venture capital investment in pharmaceutical logistics startups, along with global logistics majors expanding cold chain capacity (e.g., DHL, UPS, Kuehne+Nagel), further reflect growing market interest. As climate change, global health threats, and demand for equitable vaccine access reshape the global health landscape, the vaccine logistics market will remain central to delivering immunization outcomes at scale-across urban centers, rural outposts, and everything in between.

SCOPE OF STUDY:

The report analyzes the Vaccine Logistics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Service (Transportation Service, Warehousing Service, Value-Added Services); End-User (Hospitals End-User, Drug Manufacturers & Distributors End-User, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

  • 3PL-Agility
  • AIT Worldwide Logistics
  • AIT Worldwide Logistics
  • AllCargo Logistics
  • American Airlines Cargo
  • Americold Logistics
  • Biocair
  • CEVA Logistics
  • Cold Chain Technologies
  • DB Schenker
  • DHL Global Forwarding
  • DP World
  • DPD/Deutsche Post AG
  • Dulas Ltd.
  • FedEx Corporation
  • Gebruder Weiss
  • IndoSurgicals Pvt. Ltd.
  • Kuehne+Nagel
  • LifeConEx (DHL subsidiary)
  • Nippon Express

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Vaccine Logistics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Global Vaccination Campaigns Throw the Spotlight on Scalable and Resilient Vaccine Logistics Infrastructure
    • Expansion of Cold Chain Networks Spurs Growth in Temperature-Controlled Storage and Transportation Solutions
    • Rising Demand for Last-Mile Delivery Efficiency Expands Addressable Market for Specialized Vaccine Distribution Services
    • Innovation in Temperature Monitoring and IoT Integration Strengthens the Business Case for Smart Vaccine Logistics
    • Increasing Use of mRNA and Biologic Vaccines Drives Adoption of Ultra-Cold Chain Logistics Technologies
    • Emerging Markets Push for Immunization Equity Fuels Investment in Rural and Remote Area Distribution Capabilities
    • Integration with National Immunization Programs Enhances Demand Forecasting and Inventory Management Systems
    • Growth in Outsourcing by Pharma Companies Supports Expansion of Specialized Vaccine Logistics Providers
    • Standardization of Packaging, Labeling, and Handling Protocols Improves Cross-Border Vaccine Movement
    • Real-Time Visibility and Exception Management Tools Improve Cold Chain Integrity and Risk Mitigation
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Vaccine Logistics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Vaccine Logistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Vaccine Logistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Vaccine Logistics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Transportation Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Transportation Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Transportation Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Warehousing Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Warehousing Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Warehousing Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Value-Added Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Value-Added Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Value-Added Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hospitals End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Drug Manufacturers & Distributors End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Drug Manufacturers & Distributors End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Drug Manufacturers & Distributors End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • JAPAN
    • Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • CHINA
    • Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: China 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: China 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • EUROPE
    • Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Vaccine Logistics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Vaccine Logistics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Vaccine Logistics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • FRANCE
    • Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: France 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: France 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • GERMANY
    • Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Logistics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Vaccine Logistics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Vaccine Logistics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • INDIA
    • Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: India 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: India 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Vaccine Logistics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Vaccine Logistics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Vaccine Logistics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Vaccine Logistics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Vaccine Logistics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Vaccine Logistics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030
  • AFRICA
    • Vaccine Logistics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Vaccine Logistics by Service - Transportation Service, Warehousing Service and Value-Added Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Vaccine Logistics by Service - Percentage Breakdown of Value Sales for Transportation Service, Warehousing Service and Value-Added Services for the Years 2014, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Vaccine Logistics by End-user - Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Vaccine Logistics by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Drug Manufacturers & Distributors End-User and Other End-Users for the Years 2014, 2025 & 2030

IV. COMPETITION